Detalles de la búsqueda
1.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Lancet Oncol
; 25(5): e205-e216, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697166
2.
Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.
Eur J Haematol
; 109(6): 749-754, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36066204
3.
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Br J Haematol
; 194(3): 496-507, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724461
4.
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.
Eur J Haematol
; 106(4): 546-554, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33471414
5.
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT.
Biol Blood Marrow Transplant
; 26(9): 1559-1566, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417491
6.
Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?
Eur J Haematol
; 103(6): 588-596, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31487754
7.
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma.
Eur J Haematol
; 103(3): 247-254, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231833
8.
CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?
Haematologica
; 108(10): 2568-2569, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891744
9.
Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients.
Eur J Haematol
; 100(4): 386-388, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29226427
10.
Response to Caravita di Toritto and Rago.
Eur J Haematol
; 110(2): 224-225, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300846
11.
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.
Ann Hematol
; 95(6): 967-72, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994010
12.
Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
Eur J Haematol
; 96(1): 46-54, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25779478
13.
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(6): 1054-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25708221
14.
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 21(12): 2039-2051, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26428082
15.
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 189(5): e213-e217, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32301111
16.
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.
Blood
; 121(25): 5055-63, 2013 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23482933
17.
Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population.
Br J Haematol
; 164(5): 684-93, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24313224
18.
Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma--a retrospective population based study of 1162 patients.
Eur J Haematol
; 92(1): 19-25, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24118547
19.
Approach to the treatment of multiple myeloma: a clash of philosophies.
Blood
; 118(12): 3205-11, 2011 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21791430
20.
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Blood
; 117(23): 6063-73, 2011 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21447828